Skip to content

Debt-to-assets at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
0.3×0.0×
Stryker logo
StrykerSYK
0.3×-0.1×
Axogen logo
AxogenAXGN
0.1×-0.3×
Globus Medical logo
Globus MedicalGMED
0.0×
AbbVie logo
AbbVieABBV
0.5×0.0×
Medtronic logo
MedtronicMDT
0.3×0.0×

Other financials

Income statement

See full
Revenue$391.9M+2.4%
Gross profit$217.0M+11.6%
Operating income$11.5M+174%
Net income-$4.6M+81.7%
EPS (diluted)-$0.06+81.8%

Balance sheet

See full
Cash & equivalents$236.8M-1.0%
Total debt$2.0B+3.2%
Total equity$1.0B-31.6%
Total assets$3.6B-11.7%

Cash flow

See full
Operating cash flow$9.8M+187%
CapEx$14.8M-48.7%
Free cash flow-$5.0M+87.4%

Valuation

See full
Market cap$1.38B-56.8%
Enterprise value$3.12B-26.7%
P/S0.8×-1.1×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin-29.8%-30.3pp
Net margin-30.1%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-38.6%
Debt / equity1.9×+0.6×
Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

Based on the most recent quarter.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Integra LifeSciences's debt-to-assets?
Integra LifeSciences (IART) reported debt-to-assets of 0.6× in Q1 2026.
How has Integra LifeSciences's debt-to-assets changed year-over-year?
Integra LifeSciences's debt-to-assets increased by 16.8% year-over-year, from 0.5× to 0.6×.
What is the long-term trend for Integra LifeSciences's debt-to-assets?
Over 5 years (2020 to 2025), Integra LifeSciences's debt-to-assets has grown at a 13.1% compound annual growth rate (CAGR), from 0.3× to 0.5×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.